Geode Capital Management, LLC Rubius Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.14 - $0.31 $3,279 - $7,262	-23,428 Reduced 5.38%	412,218 $70,000
Q2 2022 Aug 12, 2022	SELL	$0.79 - $5.98 $264,642 - $2 Million	-334,990 Reduced 43.47%	435,646 $370,000
Q1 2022 May 13, 2022	BUY	$4.25 - $10.4 $1,130 - $2,766	266 Added 0.03%	770,636 $4.25 Million
Q4 2021 Feb 11, 2022	SELL	$9.68 - $17.74 $282,055 - $516,908	-29,138 Reduced 3.64%	770,370 $7.46 Million
Q3 2021 Nov 12, 2021	SELL	$17.6 - $25.91 $242,686 - $357,272	-13,789 Reduced 1.7%	799,508 $14.3 Million
Q2 2021 Aug 13, 2021	BUY	$22.26 - $28.43 $2.11 Million - $2.69 Million	94,744 Added 13.19%	813,297 $19.9 Million
Q1 2021 May 12, 2021	BUY	$8.02 - $32.01 $1.08 Million - $4.3 Million	134,421 Added 23.01%	718,553 $19 Million
Q4 2020 Feb 12, 2021	SELL	$4.23 - $8.73 $95,103 - $196,276	-22,483 Reduced 3.71%	584,132 $4.43 Million
Q3 2020 Nov 13, 2020	BUY	$4.65 - $6.25 $61,993 - $83,325	13,332 Added 2.25%	606,615 $3.04 Million
Q2 2020 Aug 13, 2020	BUY	$4.01 - $6.88 $168,909 - $289,799	42,122 Added 7.64%	593,283 $3.55 Million
Q1 2020 May 14, 2020	BUY	$3.74 - $9.84 $143,208 - $376,783	38,291 Added 7.47%	551,161 $2.45 Million
Q4 2019 Feb 13, 2020	BUY	$7.23 - $14.12 $151,830 - $296,520	21,000 Added 4.27%	512,870 $4.87 Million
Q3 2019 Nov 12, 2019	BUY	$7.85 - $15.75 $1.23 Million - $2.46 Million	156,230 Added 46.55%	491,870 $3.86 Million
Q2 2019 Aug 14, 2019	BUY	$13.5 - $19.94 $418,716 - $618,459	31,016 Added 10.18%	335,640 $5.28 Million
Q1 2019 May 14, 2019	BUY	$13.27 - $18.51 $1.41 Million - $1.96 Million	106,087 Added 53.43%	304,624 $5.51 Million
Q4 2018 Feb 13, 2019	BUY	$13.83 - $22.97 $507,450 - $842,815	36,692 Added 22.67%	198,537 $3.19 Million
Q3 2018 Nov 13, 2018	BUY	$20.06 - $26.94 $3.25 Million - $4.36 Million	161,845 New	161,845 $3.88 Million

Others Institutions Holding RUBY

# of Institutions

Shares Held

325

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

325
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Rubius Therapeutics, Inc.

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

More about RUBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account